Instinct Bio Technical Company Holdings Inc (BIOT) Stock AnalysisBIOTInstinct Bio Technical Company Holdings Inc

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others. It operates in the Consumer Non-Cyclicals sector.

Currently, Relativity Holdings Inc. (BIOT) is not a good buy. The stock has seen a staggering year-to-date change of -99.50%, indicating severe underperformance. Additionally, the RSI is at a very low 6.955, suggesting that the stock is extremely oversold. The stock's price is currently at 0.18, which is significantly below its 200-day simple moving average of 1.211, indicating a strong downtrend. The main risk is the lack of any positive financial metrics, as the forward P/E ratio is 0, which means there are no earnings expected in the near future. Overall, the combination of extreme price decline and poor fundamentals suggests that investors should avoid buying BIOT at this time.